| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/14/2004 | EP1379665A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 01/14/2004 | EP1379661A2 Regulation of human gnat acetyltransferase-like protein |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379651A2 Human genes and gene expression products isolated from human prostate |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379649A2 Calcium binding proteins |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379638A2 Implantation serine proteinases |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379630A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 01/14/2004 | EP1379624A2 Transfection of human embryonic stem cells |
| 01/14/2004 | EP1379554A2 Proteins, polynucleotides encoding them and methods of using the same |
| 01/14/2004 | EP1379548A2 Novel rgs9 protein binding interactions and methods of use thereof |
| 01/14/2004 | EP1379337A1 Generation of pharmaceutical agent particles using focused acoustic energy |
| 01/14/2004 | EP1379139A2 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 01/14/2004 | EP1379134A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 01/14/2004 | EP1379133A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468305A Modulation of the transcription of pro-inflammatory gene products |
| 01/14/2004 | CN1468302A Gsk3 polypeptides |
| 01/14/2004 | CN1468093A Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467295A Method for producing blood vessel diseases gene medicine-blood vessel endothelium growth gene-2 naked DNA by microorganism cloning vehicle |
| 01/14/2004 | CN1134537C Preparation of human primitive mesenchymal stem cell population |
| 01/14/2004 | CN1134452C Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/14/2004 | CN1134260C Method of treatment for lung diseases using antisense oligonucleotides |
| 01/13/2004 | US6677319 Phosphatidylcholine as medication with protective effect large intestinal mucosa |
| 01/13/2004 | US6677313 Method for gene therapy using nucleic acid loaded polymeric microparticles |
| 01/13/2004 | US6677311 Inducible HSV-TK in transformed cell populations |
| 01/13/2004 | US6677307 TGF-α polypeptides, functional fragments and methods of use therefor |
| 01/13/2004 | US6677300 Treatment of microvascular angiopathies |
| 01/13/2004 | US6677155 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
| 01/13/2004 | US6677153 Antisense antibacterial method and composition |
| 01/13/2004 | US6677152 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene |
| 01/13/2004 | US6677135 Ret ligand (RetL) for stimulating neutral and renal growth |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6677117 Inducing cell differentiation |
| 01/13/2004 | US6676935 Transfection target cells; genetic engineering |
| 01/08/2004 | WO2004003209A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | WO2004003201A2 Antisense modulation of lrh1 expression |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003182A2 Homozygous stem cells isolated from pathogenic oocytes |
| 01/08/2004 | WO2004003170A2 Agents capable of inhibiting ras and uses thereof |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004003157A2 Gene regulation in transgenic animals using a transposon-based vector |
| 01/08/2004 | WO2004003145A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | WO2004002535A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 01/08/2004 | WO2004002517A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002459A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002416A2 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | WO2004002367A1 Drug eluting stent |
| 01/08/2004 | WO2004002296A2 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 01/08/2004 | WO2003093455A3 Adenovirus vectors for immunotherapy |
| 01/08/2004 | WO2003092579A3 Compositions and methods for treating cancer with an oncolytic viral agent |
| 01/08/2004 | WO2003091387A3 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 01/08/2004 | WO2003085090A3 A human ribonucleotide reductase m2 subunit |
| 01/08/2004 | WO2003070969A3 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/08/2004 | WO2003050238A3 Receptor-targeted adenoviral vectors |
| 01/08/2004 | WO2003050135A3 Use a parapox b2l protein to modify immune responses to administered antigens |
| 01/08/2004 | WO2003045965A3 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 01/08/2004 | WO2003039382A3 System for processing tissue |
| 01/08/2004 | WO2003022224A3 Cox-2 function and wound healing |
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | WO2003020205A3 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 01/08/2004 | WO2003008533A3 Method for virus propagation |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002072796A3 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002066654A3 Drug metabolizing enzymes |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002055697A3 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 01/08/2004 | WO2002055110A3 Methods for treating blood coagulation disorders |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002048397A3 Regulation of human adenylate cyclase, type vii |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | WO2002046225A3 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 01/08/2004 | WO2002045737A3 Methods of treatment involving human mda-7 |
| 01/08/2004 | WO2001079524A3 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 01/08/2004 | US20040006789 Pseudomonas syringae harpins, HopPtoP and HopPmaHpto, and their uses |
| 01/08/2004 | US20040006777 Comprises nucleotide sequences coding cytoplasmic phosphatases for treating and preventing tumors and metastasis; immunosuppressant |
| 01/08/2004 | US20040006210 Human polyhomeotic 2 (hph2) acts as an oncogene |
| 01/08/2004 | US20040006029 Antisense modulation of cell division cycle 2 expression |
| 01/08/2004 | US20040006004 This invention concerns a method for treating or preventing a disease or disorder related to excessive formation of vascular tissue or blood vessels in a patient, said method comprising administering to said patient an agent affecting the NPY Y2 |
| 01/08/2004 | US20040006003 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/08/2004 | US20040005711 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 01/08/2004 | US20040005710 Method for producing recombinant viruses using site-specific recombination |
| 01/08/2004 | US20040005708 For gene therapy, transferring therapeutic genes into cells |
| 01/08/2004 | US20040005707 Antisense modulation of integrin beta 5 expression |
| 01/08/2004 | US20040005704 Propagating neuronal cells in reduced oxygen environment for treating parkinson's and neurodegenerative diseases; in vitro culture and cell differentiation/proliferation; gene therapy; tissue engineering; antiapoptosis |
| 01/08/2004 | US20040005702 Immortalized human pancreatic cell line produced by electrofusion and which secretes insulin for treating diabetes; gene therapy; tissue engineering |
| 01/08/2004 | US20040005688 Comprises dishevelled associated kinase (DAK) protein for diagnosis, prevention and treatment of cell proliferative diseases |
| 01/08/2004 | US20040005670 Compositions and methods for the treatment of hemophilia A |
| 01/08/2004 | US20040005667 Comprises protein for developing vaccines which prevent chlamydial infections; genetic vaccines |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |